- Presentations
- 2
- Markets
- 1
SymlinPen is a brand of Pramlintide marketed by AstraZeneca Pharmaceuticals, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Pramlintide
- Brand owner
- AstraZeneca Pharmaceuticals
- Registered in
- United States
- Strengths and forms
- 1500 mcg/1.5 mL injection, 2700 mcg/2.7 mL injection
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| SymlinPen 1500 mcg/1.5 mL injectionSubcutaneous Cold chain | AstraZeneca Pharmaceuticals | US FDA | Available on request |
| SymlinPen 2700 mcg/2.7 mL injectionSubcutaneous Cold chain | AstraZeneca Pharmaceuticals | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request SymlinPen
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.